Back to User profile » Dr Karin Mirzaev
Papers published by Dr Karin Mirzaev:
MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D
Pharmacogenomics and Personalized Medicine 2021, 14:1575-1582
Published Date: 2 December 2021
Variation of Genomic Sites Associated with Severe Covid-19 Across Populations: Global and National Patterns
Balanovsky O, Petrushenko V, Mirzaev K, Abdullaev S, Gorin I, Chernevskiy D, Agdzhoyan A, Balanovska E, Kryukov A, Temirbulatov I, Sychev D
Pharmacogenomics and Personalized Medicine 2021, 14:1391-1402
Published Date: 4 November 2021
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV
Pharmacogenomics and Personalized Medicine 2020, 13:29-37
Published Date: 23 January 2020
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty [Corrigendum]
Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T
Pharmacogenomics and Personalized Medicine 2018, 11:167-168
Published Date: 26 September 2018
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty
Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T
Pharmacogenomics and Personalized Medicine 2018, 11:127-137
Published Date: 25 July 2018
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
Rytkin E, Mirzaev KB, Grishina EA, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Giliarov MI, Andreev DA, Sychev DA
Pharmacogenomics and Personalized Medicine 2017, 10:243-245
Published Date: 18 September 2017
CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome
Mirzaev KB, Zelenskaya EM, Barbarash OL, Ganyukov VI, Apartsin KA, Saraeva NO, Nikolaev KY, Ryzhikova KA, Lifshits GI, Sychev DA
Pharmacogenomics and Personalized Medicine 2017, 10:107-114
Published Date: 12 April 2017